‘Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer – Pipeline Review, H1 2015′, provides an overview of the Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer’s therapeutic pipeline.
This report provides comprehensive information on the therapeutic development...
More...





